Abstract:This preliminary study suggests that the new technique of thoracoscopic thermal ablation therapy is a less invasive optional therapy for HCC located in segments VII or VIII in cirrhotic patients.
“…Yamashita et al [8] delivered thoracoscopic transdiaphragmatic microwave coagulation for primary and secondary hepatic tumors to six patients with no perioperative complications and no recurrence after a median follow-up of 17 months. Ishikawa et al [4] performed thoracoscopic RFA for nine patients with similar good results. These reports suggest that thoracoscopic ablation is technically feasible and safe.…”
“…Yamashita et al [8] delivered thoracoscopic transdiaphragmatic microwave coagulation for primary and secondary hepatic tumors to six patients with no perioperative complications and no recurrence after a median follow-up of 17 months. Ishikawa et al [4] performed thoracoscopic RFA for nine patients with similar good results. These reports suggest that thoracoscopic ablation is technically feasible and safe.…”
“…Some authors consider that for lesions located beneath the diaphragm laparoscopic approach can be associated [13] or even replaced with the thoracoscopic one [14,15].…”
“…Microwave irradiation is carried out for about 60 seconds at a power setting of 60W per pulse. During irradiation, the ultrasonographic probe is placed adjacent to the microwave electrode to monitor the effectiveness of the tumour coagulation [11], [12]. A typical microwave generator costs approximately $65,000 [13].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.